NEW YORK (GenomeWeb News) – Zebrafish screening firm Znomics said yesterday that it is collaborating with the University of Utah’s Huntsman Cancer Institute to develop pre-clinical compounds to treat T-cell leukemia, autoimmune diseases, inflammation, and complications related to organ transplantation.
 
Znomics said in a statement that it will fund the program and “receive full commercial rights to the discoveries.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.